Regulatory T cells: A target in anticancer immunotherapy.
Regulatory T cells (Tregs) expressing the transcription factor Foxp3 play a crucial role in maintaining peripheral immune tolerance and preventing autoimmunity. With being abun- dant in tumor tissue, they promote tumor progression by suppressing effective antitumor im- munity. Additionally, recent progresses suggest that Tregs comprise functionally distinct subsets and contribute differently to cancer prognosis. Thus, there has been considerable interest in integration of strategies restricting Tregs-mediated immune suppression by selec- tively reducing Tregs or attenuating their suppressive activity with activating tumor-specific effector T cells. Understanding mechanisms for abundance of Tregs in tumors is crucial for developing optimal Tregs-mediated immunotherapy.